1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Agilent Acquires ACEA Biosciences

M&A Deal Summary

Agilent Acquires ACEA Biosciences

On September 25, 2018, Agilent acquired medical products company ACEA Biosciences for 250M USD

Acquisition Highlights
  • This is Agilent’s 6th transaction in the Medical Products sector.
  • This is Agilent’s 8th largest (disclosed) transaction.
  • This is Agilent’s 24th transaction in the United States.
  • This is Agilent’s 12th transaction in California.

M&A Deal Summary
Date 2018-09-25
Target ACEA Biosciences
Sector Medical Products
Buyer(s) Agilent
Deal Type Add-on Acquisition
Deal Value 250M USD

Target

ACEA Biosciences

San Diego, California, United States
ACEA Biosciences, Inc. is a developer of cutting-edge cell analysis instruments for life science research and clinical diagnostics. ACEA Biosciences, Inc. was founded in 2002 and is based in San Diego, California.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Agilent

Santa Clara, California, United States
Category Company
Founded 1999
Sector Test/Measurement Equipment
Employees17,600
Revenue 6.5B USD (2024)
DESCRIPTION
Entrance to Agilent's headquarters in Santa Clara, California.
Entrance to Agilent's headquarters in Santa Clara, California.

Agilent produces instruments, software, services, and consumables solutions for the entire laboratory workflow. The company's life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Agilent was founded in 1999 and is based in Santa Clara, California.

DEAL STATS #
Overall 31 of 38
Sector: Medical Products M&A 6 of 7
Type: Add-on Acquisition M&A Deals 28 of 35
State: California M&A 12 of 13
Country: United States M&A 24 of 28
Year: 2018 M&A 7 of 7
Size (of disclosed) 8 of 12
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-06-28 ProZyme

Hayward, California, United States

ProZyme, Inc. is a provider of value-added kits, enzymes, standards and a complete CE system for biotherapeutic protein characterization and glycobiology research. ProZyme was founded in 1990 and is based in Hayward, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-07-11 BioTek Instruments

Winooski, Vermont, United States

BioTek Instruments, Inc. is a designer, manufacturer, and distributor of innovative life science instrumentation. BioTek Instruments was founded in 1968 and is based in Winooski, Vermont.

Buy $1.7B
Mergr

Solution for

Product

Company

Legal